Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Neoplasms × Everolimus × Clear all

Phase

Status

Completed 17 Terminated 11 Unknown 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Tongue Neoplasms 1 Sturge-Weber Syndrome 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Port-Wine Stain 1 Peutz-Jeghers Syndrome 1 Neuroendocrine Tumors 1 Neoplastic Processes 1 Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Glaucoma 1 Epilepsy 1 Carcinoma, Renal Cell 1

Interventions

Cisplatin 9 pembrolizumab 5 Radiosurgery 5 Gemcitabine 5 Taxes 4 Paclitaxel 4 Dexamethasone 4 trametinib 3 ibrutinib 3 Surveys and Questionnaires 3 Standard of Care 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Fluorouracil 3 Carboplatin 3 Ascorbic Acid 3 tocilizumab 2 pazopanib 2 obinutuzumab 2 naquotinib 2 lenvatinib 2 fludarabine 2 enzalutamide 2 Trastuzumab 2 Surgical Procedures, Operative 2 SS1(dsFv)PE38 2 Radiation Dose Hypofractionation 2 Pemetrexed 2 Ondansetron 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01178151 2015-04-22

EVAMP

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Withdrawn

Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡